Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Nature Communications
|
April 1, 2025
Author Correction: A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model
Tien Duc Nguyen, Hoang Duy Le, Giang Chau Dang, et al.
Nature Communications
|
March 25, 2025
A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model
Tien Duc Nguyen, Hoang Duy Le, Giang Chau Dang, et al.
JACC. Case Reports
|
November 3, 2025
Rare Case of a Complex Coronary Triad Repaired via Axillary Thoracotomy in an Infant
Tue Minh Vo, Dung Duc Nguyen, Hung Xuan Nguyen, et al.
Oncogene
|
July 24, 2025
Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella
Thanh Quang Tran, Taner Duysak, Kwangsoo Kim, et al.
Research Square
|
May 10, 2023
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients
Stephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Breast Cancer Research and Treatment
|
May 31, 2019
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
Melissa Krystel-Whittemore, Jin Xu, Edi Brogi, et al.
JACC. Heart Failure
|
June 11, 2026
Withdrawal of Guideline-Directed Medical Therapy in Heart Failure With Improved Ejection Fraction: A Systematic Review and Meta-Analysis With Trial Sequential Analysis
Amira Mohamed Taha, Dang Nguyen, Marwa Muhammed Abdeljawad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
Chau Dang, Nancy Lin, Beverly Moy, et al.
Breast Cancer Research and Treatment
|
October 13, 2023
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients
Stephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Breast Cancer Research and Treatment
|
March 4, 2014
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
Kathryn J Ruddy, Anne O'Neill, Kathy D Miller, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Nature Communications
|
April 1, 2025
Author Correction: A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model
Tien Duc Nguyen, Hoang Duy Le, Giang Chau Dang, et al.
Nature Communications
|
March 25, 2025
A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model
Tien Duc Nguyen, Hoang Duy Le, Giang Chau Dang, et al.
JACC. Case Reports
|
November 3, 2025
Rare Case of a Complex Coronary Triad Repaired via Axillary Thoracotomy in an Infant
Tue Minh Vo, Dung Duc Nguyen, Hung Xuan Nguyen, et al.
Oncogene
|
July 24, 2025
Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella
Thanh Quang Tran, Taner Duysak, Kwangsoo Kim, et al.
Research Square
|
May 10, 2023
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients
Stephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Breast Cancer Research and Treatment
|
May 31, 2019
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
Melissa Krystel-Whittemore, Jin Xu, Edi Brogi, et al.
JACC. Heart Failure
|
June 11, 2026
Withdrawal of Guideline-Directed Medical Therapy in Heart Failure With Improved Ejection Fraction: A Systematic Review and Meta-Analysis With Trial Sequential Analysis
Amira Mohamed Taha, Dang Nguyen, Marwa Muhammed Abdeljawad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
Chau Dang, Nancy Lin, Beverly Moy, et al.
Breast Cancer Research and Treatment
|
October 13, 2023
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients
Stephanie Gu, Stephen Dusza, Elizabeth Quigley, et al.
Breast Cancer Research and Treatment
|
March 4, 2014
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
Kathryn J Ruddy, Anne O'Neill, Kathy D Miller, et al.
Page
of 8